Head and Neck Cancer (HNC) is the sixth most common cancer worldwide with over 600,000 new cases diagnosed annually. The US alone has ~56,000 newly diagnosed HNC patients each year. These patients frequently bear a disproportionate burden from their cancers based on the critical anatomic location of their disease. HN tumors and treatment often compromise speech, swallow and breathing function, in addition to creating significant changes in physical appearance and social interactions. The ultimate objective of the Wisconsin Head and Neck SPORE Grant (PI: Paul Harari, MD) is to advance translational research to improve the outcome for HNC patients.
The UW SPORE Career Enhancement Program (CEP) seeks to support junior investigators, including physician scientists, to meet the challenge for innovation in methods to prevent, diagnose and advance treatment options for patients with Head and Neck Cancer (HNC).
Deadlines:
- LOI: March 9, 2018
- Application: April 6, 2018
Funding Levels:
Applicants may apply for $10K, $25K or $50K awards.
Eligibility: Applicants must meet the following criteria:
- Assistant Professor
- Have minimum of 1 day/week protected time dedicated to translational HNC research
- Have no current or previous NIH R01 or equivalent funding in HNC research
- Have UW mentor(s)1 with a research focus in HNC
See 2018 CEP funding announcement for more details.
The UW SPORE Developmental Research Program (DRP) seeks to fund pilot project applications that will attract experienced investigators to the field of Head and Neck Cancer (HNC), promote basic, clinical, and translational HNC research and potentially result in preliminary data to support successful competitive national grants (R01 or equivalent).
Deadlines:
- LOI: March 9, 2018
- Application: April 6, 2018
Funding Levels (1-2 years):
Applicants may apply for $25,000-$50,000/year.
Eligibility:
Funds from this program will support the UW Professor title series (including Assistant, Associate and full Professor).
See 2018 DRP Funding Announcement for more details.